A Phase 1 Crossover Study of Blood Pressure and Heart Rate Response

Clinical trial NCT01577459 · COMPLETED

Trial details

NCT number: NCT01577459
Sponsor: Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects

Start date: 2012-04-23
Primary completion: 2012-06-15
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.